In 2025, Novozymes completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Novozymes has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Location-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novozymes’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Novozymes amounted to 441,643 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Novozymes decreased by 0.83%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Novozymes were 106,896 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Novozymes's Scope 1 emissions have increased by 167.24%, reflecting a rising long-term trend in Scope 1 emissions over time.ac
Compared to the previous year (2024), Novozymes's Scope 1 emissions increased by 14.27%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Novozymes reported Scope 2 greenhouse gas (GHG) emissions of 52,389 tCO₂e using the market-based method and 334,747 tCO₂e using the location-based method.a
Compared to the previous year (2024), Novozymes's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Novozymes's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Novozymes reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Novozymes reported 1,188,383 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Novozymes includes a breakdown across 5 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Novozymes reported total Scope 3 emissions of 1,188,383 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2019, Novozymes's Scope 3 emissions have increased by 81.43%, reflecting a rising long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2024), Novozymes's Scope 3 emissions remained relatively stable, indicating that Novozymes's emissions have plateaued with no significant change in its value chain footprint.a
In 2025, Novozymes reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to Novozymes's Scope 3 emissions were:a
In 2025, Novozymes reported Scope 1 greenhouse gas (GHG) emissions of 106,896 tCO₂e and total revenues of USD 4,888 millions. This translates into an emissions intensity of 21.87 tCO₂e per millions USD.a
In 2025, Novozymes reported a Scope 1 emissions intensity of 21.87 tCO₂e per millions USD. Compared to the peer group median of 47.45, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Novozymes ranked 8 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Novozymes is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2025, Novozymes reported a total carbon footprint of 1,630,026 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 0.7% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Novozymes's total carbon footprint was Scope 3 emissions, accounting for 72.91% of the company's total carbon footprint, followed by Scope 2 emissions at 20.54%.a